Freedom-to-Operate Analysis Guide for Drug Repurposing
This guide explains how to check if a new use for an existing drug can be developed and used without infringing existing patents. It helps researchers perform a patent search using only web access and decide when to consult a patent attorney. It also includes advice on finding suppliers, especially when changing how the drug is made or delivered.
At a glance
Use when
Planning a drug repurposing project, assessing IP risks before investment, preparing for technology transfer or commercialization, identifying formulation and supply chain constraints
Avoid when
A comprehensive, legally binding IP opinion is required; when dealing with high-stakes commercial development without legal support; when advanced analytics or global patent database access is available and necessary
Inputs
Drug name, proposed new indication, formulation details, geographic target markets
Outputs
Preliminary freedom-to-operate assessment, list of potentially relevant patents, supplier options, recommendations for legal consultation
How it works
The guideline outlines a step-by-step methodology for conducting a Freedom-to-Operate (FtO) analysis specific to drug repurposing projects. It emphasizes accessibility by requiring only web-based tools and excluding AI or specialized software. The process includes patent landscape screening, identification of relevant claims, and assessment of freedom to develop and commercialize repurposed drugs. It also covers practical aspects such as sourcing active pharmaceutical ingredients and managing reformulation challenges. Designed for use by researchers and inventors, it supports early-stage intellectual property evaluation prior to legal consultation.
- Project
- REPO4EU
- Funding
- Horizon Europe
- Project status
- Ongoing
- HTA domains
- Aspects Beyond HTA
- Categories
- Drug Repurposing
- Assumptions
- Researchers have basic understanding of patent concepts; web-accessible patent databases are sufficient for initial screening; critical findings will be reviewed by a qualified patent attorney
- Strengths
- Accessible to non-experts, low-resource requirement, integrates scientific and IP considerations, promotes early risk identification, supports informed decisions before legal engagement
- Limitations
- Not a substitute for professional legal advice; limited to web-based, non-AI tools; may miss complex or jurisdiction-specific IP issues without attorney input
- Also known as
- FtO Analysis Guide for Drug Repurposing, REPO4EU Freedom-to-Operate Guide, How to Conduct a Freedom-to-Operate Analysis for a Drug Repurposing Project
Questions this answers
- › How can I determine if a repurposed drug is free to develop without infringing existing patents?
- › What steps should researchers take to perform an initial patent landscape assessment?
- › Which web-based resources are most useful for conducting a patent search in drug repurposing?
- › When should a researcher consult a patent attorney during a repurposing project?
- › How can suitable suppliers of active compounds be identified, especially for reformulated drugs?
- › What are the key intellectual property risks in drug repurposing and how can they be mitigated?
References & sources
Related methods
Similar by meaning
Beta record. Generated from the primary source via AI extraction and independent audit, pending final human review.